Evidence map›Paper›PMID 24205225›Full record

ArticlePloS one2013

Separation of plasmacytoid dendritic cells from B-cell-biased lymphoid progenitor (BLP) and Pre-pro B cells using PDCA-1.

Kay L Medina, Sarah N Tangen, Lauren M Seaburg, Puspa Thapa, Kimberly A Gwin, Virginia Smith Shapiro

Abstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Molecular Regulation of Differentiation in Early B-Lymphocyte Development.International journal of molecular sciences · 2018
    Review
  8. Article
  9. Article
  10. Article
  11. Characterization of the B cell response to Leishmania infection after anti-CD20 B cell depletion.International journal of clinical and experimental pathology · 2015
    Article
  12. Article
  13. Article
  14. Article
  15. Eosinophils regulate peripheral B cell numbers in both mice and humans.Journal of immunology (Baltimore, Md. : 1950) · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kay L MedinaDepartment of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America.
Sarah N Tangen
Lauren M Seaburg
Puspa Thapa
Kimberly A Gwin
Virginia Smith Shapiro

Funding

Regulation of T cell maturationR01AI083279 · NIAID · MAYO CLINIC ROCHESTER · PI SHAPIRO, VIRGINIA SMITH · 2010 to 2019
$3.8M
Molecular Events Initiating B Cell Fate DeterminationR01HL096108 · NHLBI · MAYO CLINIC ROCHESTER · PI MEDINA, KAY LYNN · 2009 to 2013
$1.9M
NHLBI NIH HHS R01 HL096108NIAID NIH HHS R01 AI083279
6 · The paper itself

Abstract

B-cell-biased lymphoid progenitors (BLPs) and Pre-pro B cells lie at a critical juncture between B cell specification and commitment. However, both of these populations are heterogenous, which hampers investigation into the molecular changes that occur as lymphoid progenitors commit to the B cell lineage. Here, we demonstrate that there are PDCA-1(+)Siglec H(+) plasmacytoid dendritic cells (pDCs) that co-purify with BLPs and Pre-pro B cells, which express little or no CD11c or Ly6C. Removal of PDCA-1(+) pDCs separates B cell progenitors that express high levels of a Rag1-GFP reporter from Rag1-GFP(low/neg) pDCs within the BLP and Pre-pro B populations. Analysis of Flt3-ligand knockout and IL-7Rα knockout mice revealed that there is a block in B cell development at the all-lymphoid progenitor (ALP) stage, as the majority of cells within the BLP or Pre-pro B gates were PDCA-1(+) pDCs. Thus, removal of PDCA-1(+) pDCs is critical for analysis of BLP and Pre-pro B cell populations. Analysis of B cell potential within the B220(+)CD19(-) fraction demonstrated that AA4.1(+)Ly6D(+)PDCA-1(-) Pre-pro B cells gave rise to CD19(+) B cells at high frequency, while PDCA-1(+) pDCs in this fraction did not. Interestingly, the presence of PDCA-1(+) pDCs within CLPs may help to explain the conflicting results regarding the origin of these cells.

Indexed as

AnimalsAntigens, CD19Antigens, LyB-LymphocytesCD11c AntigenCell DifferentiationCell LineageDendritic CellsGPI-Linked ProteinsLeukocyte Common AntigensMembrane GlycoproteinsMiceMice, Inbred C57BLMice, KnockoutPrecursor Cells, B-LymphoidReceptors, ComplementAntigens, CD19Antigens, LyCD11c Antigencomplement 1q receptorGPI-Linked Proteinsinterleukin-7 receptor, alpha chainLeukocyte Common AntigensLy6d protein, mouseMembrane GlycoproteinsReceptors, ComplementReceptors, Interleukin-7

Identifiers

PMID24205225
PMCPMC3813560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.